Rob Noorlag1, Petra van der Groep2,3, Frank K J Leusink1, Sander R van Hooff4, Michaël H Frank1, Stefan M Willems2, Robert J J van Es1. 1. Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Molecular Cancer Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
BACKGROUND: Gene expression profiling revealed a strong signature predicting lymph node metastases in oral squamous cell carcinoma (OSCC). Four of the most predictive genes are secretory leukocyte protease inhibitor (SLPI), lipocalin-2 (LCN2), thrombospondin-2 (THBS2), and tumor-associated calcium signal transducer 2 (TACSTD2). This study correlates their protein expression with lymph node metastases, overall survival (OS), and disease-specific survival (DSS). METHODS: Two hundred twelve patients with OSCC were included for protein expression analysis by immunohistochemistry. RESULTS: SLPI expression correlates with lymph node metastases in the whole cohort, not in a subgroup of cT1 to 2N0. SLPI expression correlates with OS (hazard ratio [HR] = 0.61) and DSS (HR = 0.47) in multivariate analysis. LCN2, THBS2, and TACSTD2 show no correlation with lymph node metastases, OS, or DSS. CONCLUSION: Although SLPI expression correlates with lymph node metastases, it has no additional value in determining lymph node metastases in early oral cancer. However, it is an independent predictor for both OS and DSS and therefore a relevant prognostic biomarker in OSCC.
BACKGROUND: Gene expression profiling revealed a strong signature predicting lymph node metastases in oral squamous cell carcinoma (OSCC). Four of the most predictive genes are secretory leukocyte protease inhibitor (SLPI), lipocalin-2 (LCN2), thrombospondin-2 (THBS2), and tumor-associated calcium signal transducer 2 (TACSTD2). This study correlates their protein expression with lymph node metastases, overall survival (OS), and disease-specific survival (DSS). METHODS: Two hundred twelve patients with OSCC were included for protein expression analysis by immunohistochemistry. RESULTS:SLPI expression correlates with lymph node metastases in the whole cohort, not in a subgroup of cT1 to 2N0. SLPI expression correlates with OS (hazard ratio [HR] = 0.61) and DSS (HR = 0.47) in multivariate analysis. LCN2, THBS2, and TACSTD2 show no correlation with lymph node metastases, OS, or DSS. CONCLUSION: Although SLPI expression correlates with lymph node metastases, it has no additional value in determining lymph node metastases in early oral cancer. However, it is an independent predictor for both OS and DSS and therefore a relevant prognostic biomarker in OSCC.
Authors: Christine M Pierce Campbell; Anna R Giuliano; B Nelson Torres; Michael T O'Keefe; Donna J Ingles; Rebecca L Anderson; Lauren R Teras; Susan M Gapstur Journal: Oral Oncol Date: 2016-02-24 Impact factor: 5.337
Authors: Jacklyn N Hellwege; Shirley B Russell; Scott M Williams; Todd L Edwards; Digna R Velez Edwards Journal: Ann Hum Genet Date: 2018-02-27 Impact factor: 1.670
Authors: Rebeca Kawahara; James G Bollinger; César Rivera; Ana Carolina P Ribeiro; Thaís Bianca Brandão; Adriana F Paes Leme; Michael J MacCoss Journal: Proteomics Date: 2015-12-15 Impact factor: 3.984
Authors: Norbertus A Ipenburg; Koos Koole; K Seng Liem; Pauline M W van Kempen; Ron Koole; Paul J van Diest; Robert J J van Es; Stefan M Willems Journal: Target Oncol Date: 2016-02 Impact factor: 4.493
Authors: Elgar Susanne Quabius; Immanuel Merz; Tibor Görögh; Jürgen Hedderich; Jochen Haag; Christoph Röcken; Petra Ambrosch; Markus Hoffmann Journal: Papillomavirus Res Date: 2017-06-16